News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (VRX) Receive EU Marketing Authorization for Seizure Drug



3/31/2011 7:01:30 AM

WP -- GlaxoSmithKline PLC says its seizure drug developed with Valeant Pharmaceuticals Inc. has been granted marketing authorization by the European Union. Trobalt is intended to treat partial onset seizures in adults with epilepsy. The EU approval comes after the Committee for Medicinal Products for Human Use recommended Trobalt be approved for patients who are already using another therapy. The committee makes recommendations to the European Medicines Agency.

Read at Washington Post
Read at News Release
Read at News Release
Read at News Release


comments powered by Disqus
   
Epilepsy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES